Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC drug private label makers seek more time to comply with labeling regs.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL REG: PRIVATE LABELERS SEEK MORE TIME TO COMPLY with FDA's Feb. 27 proposed revisions to over-the-counter drug labels at an agency "feedback" meeting in Rockville, Md. Sept. 30. The Private Label Manufacturers Association, which represents over 2,500 retailers, manufacturers and distributors of store brand products, likely will ask FDA for an additional year or two to come into compliance with final requirements of the OTC drug product labeling reg. The final rule revising OTC drug labeling is expected in a year and will take effect two years after issuance.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087613

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel